Bgm (BGM) Long-Term Deferred Tax (2019 - 2025)
Bgm's (BGM) quarterly Long-Term Deferred Tax came in at $246404.0 in Q3 2025, down 41.95% year-on-year from $424474.0 in Q3 2024, and down 95.12% on a QoQ basis from $5.0 million in Q1 2025.
Bgm (BGM) Long-Term Deferred Tax (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Long-Term Deferred Tax data on file, last reported at $246404.0 in Q3 2025.
- On a quarterly basis, Long-Term Deferred Tax fell 41.95% year-over-year to $246404.0 in Q3 2025; TTM through Sep 2025 was $246404.0, a 41.95% decrease from a year earlier, with the FY2025 full-year figure at $246404.0, down 41.95% from the prior year.
- Long-Term Deferred Tax for Q3 2025 stood at $246404.0, down from $5.0 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for BGM reached as high as $410.9 billion in Q1 2021 and fell as low as $10778.0 in Q3 2023.
- Historically, Long-Term Deferred Tax has averaged $84.6 billion across 5 years, with a median of $425797.0 in 2021.
- Across the five-year window, Long-Term Deferred Tax plunged 100.0% in 2024 and soared 43817.98% in 2025, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $427120.0 in 2021, then sank by 50.16% to $212876.0 in 2022, then sank by 94.94% to $10778.0 in 2023, then surged by 3838.34% to $424474.0 in 2024, then tumbled by 41.95% to $246404.0 in 2025.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $246404.0 in Q3 2025, $5.0 million in Q1 2025, and $424474.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 246,404.00 |
| Mar 31, 2025 | 5.05 Mn |
| Sep 30, 2024 | 424,474.00 |
| Mar 31, 2024 | 11,488.00 |
| Sep 30, 2023 | 10,778.00 |
| Mar 31, 2023 | 83.09 Bn |
| Sep 30, 2022 | 212,876.00 |
| Mar 31, 2022 | 352.24 Bn |
| Sep 30, 2021 | 427,120.00 |
| Mar 31, 2021 | 410.93 Bn |
| Sep 30, 2020 | 361,250.00 |
| Sep 30, 2019 | 259,384.00 |